Aslıhan Güler

13PUBLICATIONS
56CO-AUTHORS
Predictive and prognostic markersPhysiotherapyInfectious diseasesVeterinary virologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 01, 2025
PRDX-4: a novel biomarker similar to KL-6 for predicting the occurrence and progression of systemic sclerosis-ILD.

Gizem Tuğçe Alp, İbrahim Vasi, Emre Alp

|Sep 27, 2024
The Effect of Telerehabilitation-Based Self-Management Programme on Individuals With Scleroderma.

Emirhan Karakuş, Fulden Sari, Aslıhan Avanoğlu Güler

|May 30, 2024
Clinical characteristics and disease course before and after SARS-CoV-2 infection in a large cohort of systemic sclerosis patients.

Aslıhan Avanoglu Güler, Büşra Özçimen, Mesude Seda Aydoğdu

|Apr 26, 2023
Venous inflammation might be one of the features of VEXAS syndrome and associated thrombosis.

Hazan Karadeniz, Mahinur Cerit, Aslıhan Avanoğlu Güler

|Jul 21, 2022
COVID-19 in familial Mediterranean fever: Clinical course and complications related to primary disease.

Aslihan Avanoglu Guler, Tuba Yuce Inel, Timucin Kasifoglu

|Jan 03, 2022
Validation of Turkish version of the Cochin 17-item Scleroderma Functional scale.

Nurten Gizem Tore, Deran Oskay, Aslıhan Avanoglu Guler

Pageof 3